Our Team
Gretchen Miller Bowker, MS, RAC, FRAPS
Chief Executive Officer
More
Patti Hunker, MS, CCRC, CCRA
Director of Clinical Services
More
Eric English, MS, CBA, RAC
Director, RA/QA Services
More
Gretchen Parker, PhD, RAC, CIP
IRB Co-chair & Board Member, Senior Advisor
More
Allison Detling
Office Manager
More
Robert Seevers, PhD, CBA
Consultant Advisor,
Former FDA Reviewer
More
Deborah Kurtock, MT (ASCP)
Senior Clinical Research Advisor
More
Maritza Ward, RAC
RA/QA Advisor
More
Andrea Mackie
Business Development and Marketing Manager
More
Olivia Draffkorn
Regulatory Analyst
More
Heidi Unger
Senior Analyst, RA/QA
More
Ariana Jones
Senior Analyst, RA/QA Services
More
In addition to our core team, Pearl Pathways utilizes a roster of Consultant Advisors possessing deep expertise in the areas of:
- Pharmacology/Toxicology
- Formulation Development
- Analytical Chemistry
- Preclinical & Nonclinical Development
- Biostatistics
- Virology
- Microbiology
- Formulation
- Epidemiology
- Medical monitoring
Pearl Pathways also strategically partners with external vendors in the following areas to provide services that support every stage of product development:
- Drug discovery and design
- Contract drug development and manufacturing
- Analytical method development, optimization, and validation
- Pre-formulation and formulation development
- Pharmacovigilance
- Bioanalytical testing
- Data Management, Biostatistics, and Electronic Data Capture (EDC) services for clinical trials
- Market access and commercialization